LAEKNA INC
(HKEX: 2105)
Laekna, Inc. engages in the provision of clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
12.230 -
-0.450
(-3.55%)
价格区间
12.080 - 12.820
(6.13%)
开盘
12.820
昨收
12.680
买
12.230
买盘
('000)
159.5
卖
12.380
卖盘
('000)
3
成交量
('000)
1,761
成交额
21,553,090
注释
-
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
